display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced hepatocellular cancer (mHCC)
lung cancer : non small cell (NSCLC)
entrectinib ALKA-372-001, STARTRK-1, STARTRK-2 ...

Study type: